Hematopathology Fellowship
Each year, the Hematopathology department receives about 18,000 bone marrow specimens and 4,000 lymph node and other tissue specimens. It performs 25,000 cytogenetic tests, 80,000 molecular diagnostic tests, and 30,000 flow cytometry immunophenotypic studies. This volume, combined with about 30 dedicated and experienced faculty members, provides a unique learning environment and opportunities for translational research.
The Hematopathology department's fellowship program has two components:
The Hematopathology Fellowship is a one-year ACGME accredited program, completion of which fulfills the requirements for board certification in hematopathology.
The Advanced Hematopathology Fellowship is a one-year non-accredited program, which is designed to create a solid academic foundation and further improve diagnostic skills.
Fellows benefit dramatically from completion of both programs. As a result, candidates who make a two-year commitment are preferred. However, we do make exceptions and have accepted candidates to complete only the one-year Hematopathology fellowship. Therefore, strong candidates desiring to complete only Hematopathology fellowship are also encouraged to apply.
A Letter from our Program Director
It is my privilege to welcome you to learn about our Hematopathology Fellowship Program at The University of Texas MD Anderson Cancer Center. Consistently recognized as one of the top cancer centers in the world, and uniquely positioned within the extraordinary Texas Medical Center, MD Anderson offers tremendous opportunities and resources to hematopathology trainees.
Education is one of the core pillars of the Department of Hematopathology. The Hematopathology Fellowship Program, which began in 1988, currently has seven fellows every year. Our vision is to foster a culture where fellows have the opportunity to reach their highest potential. Our fellowship program is designed to develop and train the next generation of leaders in our field. With this explicit directive in mind, we craft the fellows’ clinical experience, educational program, research opportunities and professional development. Our Hematopathology Fellowship Program has two components: (1) a one-year ACGME accredited program, completion of which fulfills the requirements for board certification in hematopathology; (2) an additional non-accredited year designed to create a solid academic foundation and further improve diagnostic skills. Our fellows are highly involved in all aspects of our departmental operations, including patient care, research, and multidisciplinary conferences.
One of the strengths of our program is the enormous quantity and excellent quality of hematopathology cases with a good variety of common and uncommon entities. Each year, the Hematopathology department receives about 18,000 bone marrow specimens and 4,000 lymph node and other tissue biopsy specimens. In addition, the department performs about 25,000 cytogenetic tests, 80,000 molecular diagnostic tests, and 30,000 flow cytometry immunophenotypic studies. This volume, combined with about 30 dedicated and experienced faculty members, provides a unique learning environment and opportunities for translational research.
The faculty and I are strongly committed to each fellow’s success in their fellowship and subsequent independent careers. We are fortunate to have outstanding hematopathology faculty including world-class experts and forward-thinking leaders. Our faculty enthusiastically share their expertise through sign-out sessions, teaching conferences, research meetings and career planning. Through dedicated teaching and mentorship, our hematopathology fellows mature into sophisticated experts in the management of neoplastic and non-neoplastic hematopathology disorders. Many of our fellows have become leaders in the field of hematopathology nationally and internationally.
Specifically drawing upon the unwavering institutional commitment to research and innovative science, we offer fellows unparalleled exposure, involvement, and experience in hematopathology research activities. This exposure allows our
fellows to use evidence-based medicine in presentations at local/regional, as well as national/international meetings and to produce manuscripts for peer-review publications. Our fellows gain proficiency in translational research with an emphasis on critical appraisal of the literature and research design to achieve the highest impact in health care through the accurate diagnoses of hematopathology disorders.
MD Anderson is a special place where every person is dedicated to our mission to end cancer while exhibiting the core values of Caring, Integrity, Discovery, Safety and Stewardship. We are extremely proud of our fellows as they continue to embody this spirit in their extraordinary careers.
Thank you for considering the Hematopathology Fellowship Program at MD Anderson. We look forward to further interacting with you about our fellowship our program.
Meet our Current Fellows
Advanced Hematopathology/Chief Fellows (second year)
Xenia Parisi, M.D.
Qing Wei, M.D., Ph.D.
Paul Young, M.D.
Hematopathology (first year)
Anindita Ghosh, M.D., Ph.D.
Azeem Khan, M.D.
Wei Wang, M.D.
Peter Wanes, M.D.
Our Alumni
2023
Shuyu E, M.D., Ph.D.
Sameeta, M.D.
Yiannis Petros Dimopoulos, M.D.
Roman Gonta, M.D.
Xenia Parisi, M.D.
Qing Wei, M.D.
Paul Young, M.D.
2022
Akash, M.D.
Do Hwan Kim, M.D.
Karen A. Nahmod, M.D., Ph.D.
O. Valentine Nwogbo, M.D.
Shuyu E, M.D., Ph.D.
Priyatharsini Nirmalanatham, M.D.
Sameeta, M.D.
2021
Lianqun Qiu, M.D., Ph.D.
Xiaoqiong Wang, M.D., Ph.D.
Akash, M.D.
Jeong Hee Cho, M.D.
Do Hwan Kim, M.D.
Karen A. Nahmod, M.D., Ph.D.
O. Valentine Nwogbo, M.D.
Contact Information
Jie Xu, M.D., Ph.D.
Director, Hematopathology Fellowship Program
Department of Hematopathology
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Unit 0072
Houston, TX 77030-4905
For additional information, please contact:
Yvette Bañuelos
Program Coordinator
Phone: 713-745-4798
Fax: 713-563-3166
Email: ybanuelos@mdanderson.org
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.
Our Labs
Learn more about our faculty and research taking place in our labs.
Conferences
View conferences available for continuing education credit.